The Patent Finder

SignalRx Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents SignalRx Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Showing 1 to 4 of 4 · Back to SignalRx Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,981,983Thienopyranones as kinase inhibitors
Lapsed on the fee record
Ended May 29, 2026 · USPTO record
Lapsed on the fee recordEnded May 29, 2026USPTO record
US 7,662,977PI-3 kinase inhibitor prodrugs
Lapsed on the fee record
Ended Feb 16, 2022 · USPTO record
Lapsed on the fee recordEnded Feb 16, 2022USPTO record
US 7,396,828PI-3 kinase inhibitor prodrugs
Lapsed on the fee record
Ended Jul 8, 2016 · USPTO record
Lapsed on the fee recordEnded Jul 8, 2016USPTO record
US 6,949,537PI-3 kinase inhibitor prodrugs
Lapsed on the fee record
Ended Sep 27, 2013 · USPTO record
Lapsed on the fee recordEnded Sep 27, 2013USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited